Evidence map›Paper›PMID 32434784›Full record

ArticleJournal of clinical microbiology2020

Optimizing a Screening Protocol for Potential Extended-Spectrum β-Lactamase Escherichia coli on MacConkey Agar for Use in a Global Surveillance Program.

Megan E Jacob, Shivaramu Keelara, Awa Aidara-Kane, Jorge R Matheu Alvarez, Paula J Fedorka-Cray

Abstract read
In one paragraph

Article in Journal of clinical microbiology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. No evidence of multidrug-resistantMicrobiology spectrum · 2025
    Observational
  6. Article
  7. Agriculturally Sourced Multidrug-ResistantPathogens (Basel, Switzerland) · 2025
    Article
  8. Article
  9. Article
  10. Extended-spectrumFrontiers in microbiology · 2025
    Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. CTX-M-producingOne health (Amsterdam, Netherlands) · 2023
    Article
  17. Article
  18. Pandemic one health clones ofFrontiers in cellular and infection microbiology · 2023
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Megan E Jacob *Department of Population Health and Pathobiology, College of Veterinary Medicine, North Carolina State University, Raleigh, North Carolina, USA.
Shivaramu Keelara *Department of Population Health and Pathobiology, College of Veterinary Medicine, North Carolina State University, Raleigh, North Carolina, USA.
Awa Aidara-KaneDepartment of Food Safety and Zoonosis, World Health Organization (WHO), Geneva, Switzerland.
Jorge R Matheu AlvarezDepartment of Food Safety and Zoonosis, World Health Organization (WHO), Geneva, Switzerland.
Paula J Fedorka-CrayDepartment of Population Health and Pathobiology, College of Veterinary Medicine, North Carolina State University, Raleigh, North Carolina, USA pjcray@ncsu.edu.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The increasing prevalence of extended-spectrum beta-lactamase (ESBL)-producing

Indexed as

Escherichia coliEscherichia coli InfectionsAgarAnti-Bacterial Agentsbeta-LactamasesHumansKlebsiella pneumoniaeMicrobial Sensitivity TestsReproducibility of ResultsAgarAnti-Bacterial Agentsbeta-LactamasesESBLEscherichia coliglobal surveillanceMacConkey agar

Identifiers

PMID32434784
PMCPMC7448649

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.